Mediterrania leads €75m investment Moroccan pharma co in Laprophan

12-05-2023; Private Equity Wire

Mediterrania Capital Partners, a private equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, has acquired a stake in Moroccan pharmaceutical company Laprophan through its fund MC IV, alongside Germany’s development finance institution DEG, Proparco and FMO.